reviewNature MedicineNov 1, 2013Closed access

Tumor adaptation and resistance to RAF inhibitors

PLPiro LitoNRNeal RosenDBDavid B. Solit

Memorial Sloan Kettering Cancer Center

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

589
total citations
FWCI
31.71
Percentile
100%
References
114
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • Mutant
  • Melanoma
  • Drug resistance
  • Cancer research
  • MAPK/ERK pathway
  • Medicine
  • Drug
  • Kinase
No related works found for this paper.